ENTITY
Junshi Biosciences

Junshi Biosciences (1877 HK)

309
Analysis
Health Care • China
Junshi Biosciences is an innovation-driven biopharmaceutical company focused on the discovery, development, clinical research, and commercialization of innovative therapeutics. Its key products, including toripalimab injection, Etesevimab, and adalimumab injection, are used to treat malignant tumors, autoimmune diseases, chronic metabolic diseases, nervous system diseases, and infectious diseases. The company was founded in December 2012 and is headquartered in Shanghai, China.
more
Company Event • 30 Oct 2026 16:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 26 Aug 2026 08:00 • Upcoming
Add To Calendar

H1 2026

Company Event • 27 Apr 2026 08:00 • Upcoming
Add To Calendar

Q1 2026

Company Event • 13 Mar 2026 09:00 • Upcoming
Add To Calendar

H2 2025

Company Event • 28 Oct 2025 09:00 • Upcoming
Add To Calendar

Q3 2025

x